CN100375623C - 用于治疗肉鸡腹水症的复方药物 - Google Patents
用于治疗肉鸡腹水症的复方药物 Download PDFInfo
- Publication number
- CN100375623C CN100375623C CNB2005100145849A CN200510014584A CN100375623C CN 100375623 C CN100375623 C CN 100375623C CN B2005100145849 A CNB2005100145849 A CN B2005100145849A CN 200510014584 A CN200510014584 A CN 200510014584A CN 100375623 C CN100375623 C CN 100375623C
- Authority
- CN
- China
- Prior art keywords
- ascites
- treatment
- medicine
- compound medicine
- ligustrazine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 17
- 150000001875 compounds Chemical class 0.000 title claims abstract description 9
- 206010003445 Ascites Diseases 0.000 title abstract description 23
- 241000287828 Gallus gallus Species 0.000 title abstract description 18
- 235000013372 meat Nutrition 0.000 title description 2
- FINHMKGKINIASC-UHFFFAOYSA-N Tetramethylpyrazine Chemical compound CC1=NC(C)=C(C)N=C1C FINHMKGKINIASC-UHFFFAOYSA-N 0.000 claims abstract description 22
- IZEKFCXSFNUWAM-UHFFFAOYSA-N dipyridamole Chemical compound C=12N=C(N(CCO)CCO)N=C(N3CCCCC3)C2=NC(N(CCO)CCO)=NC=1N1CCCCC1 IZEKFCXSFNUWAM-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229960002768 dipyridamole Drugs 0.000 claims abstract description 6
- 230000003187 abdominal effect Effects 0.000 claims description 14
- 206010030113 Oedema Diseases 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 238000009472 formulation Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 208000024891 symptom Diseases 0.000 abstract description 19
- 230000000694 effects Effects 0.000 abstract description 13
- 235000013330 chicken meat Nutrition 0.000 abstract description 8
- 239000003651 drinking water Substances 0.000 abstract description 7
- 235000020188 drinking water Nutrition 0.000 abstract description 7
- 238000000034 method Methods 0.000 abstract description 7
- 230000004089 microcirculation Effects 0.000 abstract description 4
- 231100000957 no side effect Toxicity 0.000 abstract description 2
- 206010047141 Vasodilatation Diseases 0.000 abstract 1
- 230000004856 capillary permeability Effects 0.000 abstract 1
- 238000005354 coacervation Methods 0.000 abstract 1
- 230000024883 vasodilation Effects 0.000 abstract 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 6
- 230000000702 anti-platelet effect Effects 0.000 description 4
- 239000003146 anticoagulant agent Substances 0.000 description 4
- 230000000916 dilatatory effect Effects 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 210000003743 erythrocyte Anatomy 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 206010020772 Hypertension Diseases 0.000 description 3
- 206010021143 Hypoxia Diseases 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 239000003218 coronary vasodilator agent Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 208000002815 pulmonary hypertension Diseases 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 206010002383 Angina Pectoris Diseases 0.000 description 2
- 206010019280 Heart failures Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 208000011191 Pulmonary vascular disease Diseases 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 230000002490 cerebral effect Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000001631 hypertensive effect Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 239000011265 semifinished product Substances 0.000 description 2
- 238000012859 sterile filling Methods 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 241000272525 Anas platyrhynchos Species 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 206010007572 Cardiac hypertrophy Diseases 0.000 description 1
- JZUFKLXOESDKRF-UHFFFAOYSA-N Chlorothiazide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC2=C1NCNS2(=O)=O JZUFKLXOESDKRF-UHFFFAOYSA-N 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 208000000924 Right ventricular hypertrophy Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 238000009360 aquaculture Methods 0.000 description 1
- 244000144974 aquaculture Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000008499 blood brain barrier function Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001218 blood-brain barrier Anatomy 0.000 description 1
- 244000144987 brood Species 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000002301 combined effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 208000016097 disease of metabolism Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 229960002003 hydrochlorothiazide Drugs 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 235000013594 poultry meat Nutrition 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 210000001147 pulmonary artery Anatomy 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000010079 rubber tapping Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000035488 systolic blood pressure Effects 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
组别 | 鸡数(羽) | 总有效率(%) | |||||
期初 | 期末 | 痊愈 | 显效 | 有效 | 无效 | ||
实验组 | 100 | 82 | 70 | 5 | 3 | 4 | 78 |
对照组 | 100 | 53 | 17 | 8 | 14 | 14 | 39 |
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100145849A CN100375623C (zh) | 2005-07-21 | 2005-07-21 | 用于治疗肉鸡腹水症的复方药物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100145849A CN100375623C (zh) | 2005-07-21 | 2005-07-21 | 用于治疗肉鸡腹水症的复方药物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1732941A CN1732941A (zh) | 2006-02-15 |
CN100375623C true CN100375623C (zh) | 2008-03-19 |
Family
ID=36075696
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005100145849A Active CN100375623C (zh) | 2005-07-21 | 2005-07-21 | 用于治疗肉鸡腹水症的复方药物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100375623C (zh) |
-
2005
- 2005-07-21 CN CNB2005100145849A patent/CN100375623C/zh active Active
Non-Patent Citations (3)
Title |
---|
双嘧达莫注射液治疗肾病综合症疗效观察. 李爱顺.中国血液流变学杂志,第14卷第3期. 2004 * |
复方中药哈特维(腹水消)对肉鸡腹水综合症的预防作用研究. 乔健等.中国农业大学学报,第3卷第3期. 1998 * |
川芎嗪对肺动脉高压心肺功能的影响. 马德娴.中国中医急症,第12卷第1期. 2003 * |
Also Published As
Publication number | Publication date |
---|---|
CN1732941A (zh) | 2006-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100502692C (zh) | 一种体力恢复保健食品及其制备方法 | |
CN101267746A (zh) | 基于胍基乙酸成分的液体制剂 | |
CN104367765A (zh) | 一种用于治疗抑郁症的中药组合物及其制备方法和应用 | |
CN102772478A (zh) | 一种增强畜禽机体免疫力的中药颗粒剂 | |
CN103860715B (zh) | 一种防治家禽球虫病的复方中药提取物及其应用 | |
CN108066360A (zh) | 一种复方醋酸钠林格注射液及其制备方法 | |
CN104430179B (zh) | 仔猪的养殖方法 | |
CN102920771B (zh) | 一种用于治疗家禽球虫病的药物 | |
CN104435069B (zh) | 一种提高猪免疫功能的兽药组合物、应用及其制备方法 | |
CN100375623C (zh) | 用于治疗肉鸡腹水症的复方药物 | |
CN102068435A (zh) | 一种复方氟尿嘧啶抗肿瘤药 | |
CN102783568A (zh) | 一种饲料添加剂 | |
CN106689675A (zh) | 氨糖壮骨关节膏 | |
CN1732946B (zh) | 禽用腹水症防治药物组合物 | |
CN101199520A (zh) | 含丙磺舒的兽用β-内酰胺类抗生素复方制剂 | |
CN104288442B (zh) | 一种调节血压的中药制剂 | |
CN103861007B (zh) | 一种治疗鸡腹泻的中草药复方制剂 | |
CN102847160B (zh) | 一种畜禽用复方喹诺酮类注射液及其制备方法 | |
CN101653445A (zh) | 酪醇半乳糖苷在制备耐缺氧及抗疲劳药物中的应用 | |
CN103948591B (zh) | 一种减肥药剂 | |
CN1262270C (zh) | 左卡尼汀及其衍生物在制备防治高原病药物中的用途 | |
CN102125558A (zh) | 一种复方左亚叶酸钠氟尿嘧啶抗肿瘤药 | |
CN101829257A (zh) | 一种治疗鸡大肠杆菌病的中药口服液及其制备方法 | |
CN101433530A (zh) | 一种运动人群用维生素补充剂 | |
CN1843364A (zh) | 一种预防和治疗球虫病的药物及其使用方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee | ||
CP03 | Change of name, title or address |
Address after: Six road in Dongli Tianjin Economic Development Zone No. six Patentee after: Tianjin Ruipu Biotechnology Co., Ltd. Address before: Tianjin New Technology Industrial Park Huayuan Industrial Zone No. 2 Alex Hua Tian Road Patentee before: Tianjin Ringpu Biological Technology Group Co., Ltd. |
|
C56 | Change in the name or address of the patentee |
Owner name: TIANJIN RUIPU BIOTECHNOLOGY CO., LTD. Free format text: FORMER NAME: TIANJIN RUIPU BIOLOGICAL CO., LTD., TECHNOLOGY GROUP |
|
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Inner Mongolia Ruipu Dadi Biological Pharmaceutical Co., Ltd. Assignor: Tianjin Ruipu Biotechnology Co., Ltd. Contract record no.: 2011120000050 Denomination of invention: Compound medicine for treating meat chicken ascites Granted publication date: 20080319 License type: Exclusive License Open date: 20060215 Record date: 20110407 |
|
EC01 | Cancellation of recordation of patent licensing contract | ||
EC01 | Cancellation of recordation of patent licensing contract |
Assignee: Inner Mongolia Ruipu Dadi Biological Pharmaceutical Co., Ltd. Assignor: Tianjin Ruipu Biotechnology Co., Ltd. Contract record no.: 2011120000050 Date of cancellation: 20170411 |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170517 Address after: 014030, the Inner Mongolia Autonomous Region, Baotou rare earth hi tech Zone, No. 13, Shing Shing Road Patentee after: Inner Mongolia Ruipu Dadi Biological Pharmaceutical Co., Ltd. Address before: Six road 300300 Tianjin Dongli Economic Development Zone No. six Patentee before: Tianjin Ruipu Biotechnology Co., Ltd. |